Using CRP levels as a continuous variable and comparing these to tumour MMR status, higher CRP levels were associated with MSI tumours compared to MSS tumours (Fig. 1C and D), reaching significance in the U-CAN validation cohort (Fig. 1D). This evidence concerns the gene CRP and neoplasm.